ICOS has been widely reported as an important immune checkpoint among various cancers, including melanoma, gastrointestinal and liver cancer, gynecological cancer, breast cancer, renal clear cell carcinoma, and Merkel carcinoma. The gene discussed is ICOS; the disease is melanoma.